Policy for IDG Consortium Interaction with Other Entities (Consortia/Institutes /Associations/Biotech/Pharma)
Homepage https://druggablegenome.net/IDGPolicies#Policy7
Countries that developed this resource Denmark , United Kingdom , United States
Published in 2018
Type: Project
Description:
IDG members are encouraged to foster collaborations and interactions with individual laboratories/researchers, consortia, associations, pharma, and biotech, as well as other outside entities. The guidelines outlined here are to enhance these interactions for the benefit of sharing IDG outcomes.Collections/recommendations derived from this policy:
- This policy implements the collection IDG Project.
Taxonomic range
Knowledge Domains
Subjects
How to cite this record FAIRsharing.org: Policy for IDG Consortium Interaction with Other Entities (Consortia/Institutes /Associations/Biotech/Pharma); DOI: https://doi.org/10.25504/FAIRsharing.7KZpOx; Last edited: Dec. 19, 2019, 11:07 a.m.; Last accessed: Jan 23 2021 11:38 a.m.
Record Maintainer
Funds
NIH (Government body)
Maintains
Illuminating the Druggable Genome (IDG) consortium (Consortium)
TOP Level Data Transparency: Not available
TOP qualifying comments: Not available
Databases
No Databases Listed
Standards
No Standards Listed
Conditions of Use
Additional Information
Contact | IDG Resource Outreach and Dissemination Center |